XELJANZ / XELJANZ XR How should I take XELJANZ/XELJANZ XR/XELJANZ Oral Solution?

(tofacitinib)

How should I take XELJANZ/XELJANZ XR/XELJANZ Oral Solution?

Take XELJANZ/XELJANZ Oral Solution 2 times a day with or without food.
Take XELJANZ XR 1 time a day with or without food.
Swallow XELJANZ XR tablets whole and intact. Do not crush, split, or chew.
When you take XELJANZ XR, you may see something in your stool that looks like a tablet. This is the empty shell from the tablet after the medicine has been absorbed by your body.
If you take too much XELJANZ/XELJANZ XR/XELJANZ Oral Solution, call your healthcare provider or go to the nearest hospital emergency room right away.
For the treatment of psoriatic arthritis, take XELJANZ/XELJANZ XR in combination with methotrexate, sulfasalazine or leflunomide as instructed by your healthcare provider.
XELJANZ XR should not be used instead of XELJANZ Oral Solution.

Find XELJANZ / XELJANZ XR medical information:

Find XELJANZ / XELJANZ XR medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

XELJANZ / XELJANZ XR Quick Finder

Medication Guide

Health Professional Information

How should I take XELJANZ/XELJANZ XR/XELJANZ Oral Solution?

How should I take XELJANZ/XELJANZ XR/XELJANZ Oral Solution?

Take XELJANZ/XELJANZ Oral Solution 2 times a day with or without food.
Take XELJANZ XR 1 time a day with or without food.
Swallow XELJANZ XR tablets whole and intact. Do not crush, split, or chew.
When you take XELJANZ XR, you may see something in your stool that looks like a tablet. This is the empty shell from the tablet after the medicine has been absorbed by your body.
If you take too much XELJANZ/XELJANZ XR/XELJANZ Oral Solution, call your healthcare provider or go to the nearest hospital emergency room right away.
For the treatment of psoriatic arthritis, take XELJANZ/XELJANZ XR in combination with methotrexate, sulfasalazine or leflunomide as instructed by your healthcare provider.
XELJANZ XR should not be used instead of XELJANZ Oral Solution.
Prescribing Information
Download Prescribing Information

Health Professional Information

How should I take XELJANZ/XELJANZ XR/XELJANZ Oral Solution?

How should I take XELJANZ/XELJANZ XR/XELJANZ Oral Solution?

Take XELJANZ/XELJANZ Oral Solution 2 times a day with or without food.
Take XELJANZ XR 1 time a day with or without food.
Swallow XELJANZ XR tablets whole and intact. Do not crush, split, or chew.
When you take XELJANZ XR, you may see something in your stool that looks like a tablet. This is the empty shell from the tablet after the medicine has been absorbed by your body.
If you take too much XELJANZ/XELJANZ XR/XELJANZ Oral Solution, call your healthcare provider or go to the nearest hospital emergency room right away.
For the treatment of psoriatic arthritis, take XELJANZ/XELJANZ XR in combination with methotrexate, sulfasalazine or leflunomide as instructed by your healthcare provider.
XELJANZ XR should not be used instead of XELJANZ Oral Solution.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.